CancerFax
Yeh Ching Linn
verifiedCancerFax Verified
schoolMBBS, MRCP(UK) ยท NUS & RCP UK

Dr.ย Yeh Chingย Linn

MBBS, MRCP(UK)

Senior Consultant, Haematology

corporate_fareSingapore General Hospital, Singapore

check_circleHaematology
check_circleStem Cell Transplantation
check_circleCellular Immunotherapy
check_circleBlood Cancers
INSTITUTION
corporate_fareSingapore General Hospital
DEPARTMENT
scienceHaematology
SPECIALTY
medical_servicesStem Cell Transplantation & Cellular Therapy
LOCATION
location_onSingapore
INTERNATIONAL PATIENTS
publicInternational Patients Welcome
person

Yeh Ching Linn

MBBS, MRCP(UK)

Dr. Yeh Ching Linn is a Senior Consultant in the Department of Haematology at Singapore General Hospital and a Clinical Associate Professor with long-standing experience in haematological diseases, transplantation, and cellular immunotherapy. She holds concurrent senior consultant appointments with the SingHealth Duke-NUS Blood Cancer Centre and the SingHealth Duke-NUS Transplant Centre.

Dr. Linn graduated from the National University of Singapore in 1987 and obtained MRCP(UK) from the Royal College of Physicians, UK in 1991, after which she joined the Department of Haematology at Singapore General Hospital and has remained actively involved in clinical service, research, and teaching since. Her clinical focus spans haematopoietic stem cell transplantation, cellular therapy, and cellular immunotherapy, with a particular research interest in cytokine-induced killer cells and virus-specific T cells for leukaemia management after transplantation. She has served as principal investigator for clinical studies on autologous cytokine-induced killer cells, supported by the National Medical Research Council and SingHealth Research Funds, and holds academic appointments as Clinical Senior Lecturer at Yong Loo Lin School of Medicine, NUS, and Adjunct Associate Professor at Duke-NUS Medical School.

workspace_premium30+Years Experience
calendar_month
M
Visiting Days
public
International Patient Support

CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Yeh Ching Linn at Singapore General Hospital, subject to hospital availability and case acceptance.

stars

Why Consider Dr. Yeh Ching Linn?

Dr. Yeh Ching Linn brings over three decades of haematology experience at one of Singapore's leading tertiary hospitals, with focused expertise in stem cell transplantation, blood cancers, and cellular immunotherapy research.

emoji_events
Over 30 Years in Haematology
Dr. Linn has been a consultant haematologist at Singapore General Hospital since 1991, building a career spanning clinical service, academic teaching, and translational research in blood cancers and transplantation.
biotech
Stem Cell Transplant Expertise
She is a Senior Consultant with the SingHealth Duke-NUS Transplant Centre, with clinical interests in haematopoietic stem cell transplantation and post-transplant cellular therapy for selected patients with blood cancers and bone marrow disorders.
science
Cellular Immunotherapy Research
Dr. Linn has led clinical studies on cytokine-induced killer cells and virus-specific T cells for leukaemia after autologous and allogeneic transplantation, funded by the National Medical Research Council and SingHealth Research Funds.
local_hospital
Part of a Multidisciplinary Blood Cancer Ecosystem
As a senior consultant at both the SingHealth Duke-NUS Blood Cancer Centre and Transplant Centre, Dr. Linn works within an integrated, multidisciplinary system covering diagnosis, treatment, transplant evaluation, clinical trials, and supportive care.
verified_user

Areas of Specialisation

Advanced haematology, stem cell transplantation, and cellular immunotherapy

Dr. Yeh Ching Linn's clinical practice covers the full spectrum of haematological malignancies and blood disorders, with particular depth in haematopoietic stem cell transplantation and cellular immunotherapy approaches for complex or relapsed cases.

Clinical Specialties

Haematopoietic Stem Cell Transplantation

Advanced transplant care for selected patients with blood cancers and bone marrow failure disorders.

starsAutologous Stem Cell Transplantation
  • arrow_rightPeripheral blood stem cell mobilisation and collection
  • arrow_rightHigh-dose chemotherapy with autologous stem cell rescue for eligible patients
  • arrow_rightPost-transplant monitoring and supportive care
starsAllogeneic Stem Cell Transplantation
  • arrow_rightMatched related and unrelated donor transplantation
  • arrow_rightABO-incompatible allogeneic transplant management
  • arrow_rightGraft-versus-host disease prevention and management
  • arrow_rightLong-term transplant outcome monitoring

Cellular Immunotherapy

Research and clinical application of cell-based immune therapies after transplantation, particularly for leukaemia.

starsCytokine-Induced Killer Cell Therapy
  • arrow_rightAutologous and allogeneic CIK cell-based immunotherapy after HSCT
  • arrow_rightClinical studies combining CIK cells with immune checkpoint inhibitors against myeloid leukaemic blasts
  • arrow_rightCMV-specific cytokine-induced killer cell applications
starsVirus-Specific T Cell Therapy
  • arrow_rightThird-party donor selection for virus-specific T-cell banks
  • arrow_rightSARS-CoV-2-specific T cell production in the post-transplant setting

Blood Cancer Management

Comprehensive diagnosis and treatment planning for a broad range of haematological malignancies and bone marrow disorders.

starsLeukaemia & Myeloid Disorders
  • arrow_rightAcute myeloid and lymphoblastic leukaemia treatment planning
  • arrow_rightChronic myeloid leukaemia management with targeted and transplant approaches
  • arrow_rightMyelodysplastic syndrome diagnosis and risk stratification
  • arrow_rightMyelofibrosis and myeloproliferative neoplasm management
starsLymphoproliferative & Plasma Cell Disorders
  • arrow_rightChronic lymphocytic leukaemia treatment coordination
  • arrow_rightMultiple myeloma diagnosis and systemic treatment planning
  • arrow_rightBone marrow evaluation and biopsy interpretation
Clinical Focus Areas
check_circleAcute Leukaemia
check_circleMultiple Myeloma
check_circleMyelodysplastic Syndromes
check_circleBone Marrow Transplantation
check_circleCellular Immunotherapy
check_circleAplastic Anaemia & Thalassaemia
medical_services

Procedures Performed

Transplant, cellular therapy, and haematological cancer treatment

Dr. Yeh Ching Linn's clinical practice encompasses haematopoietic stem cell transplantation, cellular immunotherapy, systemic treatment for blood cancers, and multidisciplinary tumour board care within the SingHealth system.

Haematopoietic Stem Cell Transplantation

Transplant

Autologous and allogeneic stem cell transplant care for eligible patients with blood cancers and bone marrow failure.

Transplant Procedures
arrow_rightAutologous HSCT with high-dose chemotherapy conditioning
arrow_rightAllogeneic HSCT including ABO-incompatible transplantation
arrow_rightPeripheral blood stem cell mobilisation
arrow_rightPost-transplant complication management including GVHD

Cellular Immunotherapy

Medical Oncology

Cell-based immune therapy approaches for selected patients after haematopoietic stem cell transplantation.

Immunotherapy Approaches
arrow_rightAutologous and allogeneic cytokine-induced killer cell therapy
arrow_rightVirus-specific T cell administration
arrow_rightCombination CIK cell and checkpoint inhibitor approaches in clinical studies

Systemic Blood Cancer Treatment

Medical Oncology

Chemotherapy, immunotherapy, and targeted therapy for a broad range of haematological malignancies.

Treatment Approaches
arrow_rightChemotherapy regimens for acute and chronic leukaemia
arrow_rightTargeted therapy for CML, MDS, and myeloproliferative neoplasms
arrow_rightImmunotherapy for eligible blood cancer patients
arrow_rightSupportive care after chemotherapy and transplantation

Complex Haematological Disease Management

Complex Disease

Multidisciplinary evaluation and treatment planning for complex or relapsed haematological disorders.

Complex Disease Services
arrow_rightBone marrow failure syndrome management including aplastic anaemia
arrow_rightThalassaemia evaluation and treatment coordination
arrow_rightDeep vein thrombosis and pulmonary embolism management
arrow_rightRelapsed or refractory blood cancer treatment planning

Second Opinion & Case Review

Second Opinion

Expert second opinion for patients with complex blood cancers, transplant decisions, or treatment-refractory haematological conditions.

Second Opinion Services
arrow_rightPathology and bone marrow biopsy review
arrow_rightTransplant eligibility assessment
arrow_rightTreatment-refractory case review and alternative planning
menu_book

Research & Publications

Peer-reviewed contributions in transplantation and cellular immunotherapy

Dr. Yeh Ching Linn has an active academic publication record in haematopoietic stem cell transplantation, cellular immunotherapy, cytokine-induced killer cells, virus-specific T cells, and transplant-related outcomes, supported by the National Medical Research Council and SingHealth Research Funds.

Selected Peer-Reviewed Publications
arrow_rightThirty years of bone marrow transplantation at Singapore General Hospital โ€“ reviewed transplant outcomes over three decades
arrow_rightABO-incompatible allogeneic stem cell transplantation โ€“ outcomes and management
arrow_rightLong-term renal outcomes after allogeneic stem cell transplant
arrow_rightAutologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukaemia
arrow_rightAllogeneic cytokine-induced killer cells in patients relapsing after allogeneic transplant for haematological malignancies
arrow_rightImmune checkpoint inhibitors and cytokine-induced killer cells against myeloid leukaemic blasts
arrow_rightCMV-specific cytokine-induced killer cells โ€“ clinical applications post-HSCT
arrow_rightThird-party donor selection for virus-specific T-cell banks
arrow_rightSARS-CoV-2 specific T-cell production in the transplant setting
arrow_rightPeripheral blood stem cell mobilisation โ€“ techniques and outcomes
arrow_rightAllogeneic transplant outcomes in myelodysplastic syndrome
Clinical Trial Participation
arrow_rightPrincipal Investigator โ€“ Autologous Cytokine-Induced Killer Cells study, Singapore General Hospital (NCT00815321, ClinicalTrials.gov)
arrow_rightPrincipal Investigator โ€“ Clinical studies on CIK cells for leukaemia after autologous and allogeneic HSCT, funded by National Medical Research Council and SingHealth Research Funds
Research Profile

A detailed publication list is available through Singapore General Hospital and PubMed. CancerFax can assist patients in understanding relevant research when coordinating a consultation.

school

Education & Training

Dr. Yeh Ching Linn completed her medical training at the National University of Singapore and obtained postgraduate membership from the Royal College of Physicians, UK.

Undergraduate
MBBS
National University of Singapore
1987
Medical degree from the National University of Singapore.
Postgraduate
MRCP(UK)
Royal College of Physicians, United Kingdom
1991
Membership of the Royal College of Physicians, UK. Dr. Linn joined the Department of Haematology at Singapore General Hospital following this qualification and has remained there since.
work_history

Clinical Experience

Dr. Yeh Ching Linn has worked in the Department of Haematology at Singapore General Hospital since 1991, progressing to Senior Consultant and holding concurrent appointments with the SingHealth Duke-NUS Blood Cancer Centre and Transplant Centre, alongside academic appointments at NUS and Duke-NUS.

Senior Consultant, Haematology
Singapore General Hospital
SingHealth Duke-NUS Blood Cancer Centre & SingHealth Duke-NUS Transplant Centre
check_circleHaematopoietic stem cell transplantation
check_circleCellular immunotherapy and CIK cell research
check_circleBlood cancer diagnosis and systemic treatment
check_circlePrincipal investigator for NMRC and SingHealth-funded clinical studies
check_circleClinical Senior Lecturer, Yong Loo Lin School of Medicine, NUS
check_circleAdjunct Associate Professor, Duke-NUS Medical School, Singapore
language

Languages & International

Dr. Yeh Ching Linn consults in the following language.

๐Ÿ‡ฌ๐Ÿ‡งEnglish
Interpreter Support Available

CancerFax can coordinate professional medical interpreter support for international patients consulting at Singapore General Hospital.

CancerFax can coordinate professional medical interpreter support for international patients where required.

support_agentHow CancerFax Helps

How CancerFax Helps You Access Dr. Yeh Ching Linn

CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Yeh Ching Linn's team โ€” with full coordination from initial inquiry to consultation.

description

Medical Report Review

Free review of your pathology results, imaging, molecular profiling, and treatment history โ€” prepared as a structured clinical summary for Dr. Yeh Ching Linn's team.

medical_services

Treatment Eligibility Screening

CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Yeh Ching Linn before you travel, so you arrive with a clear pathway.

send

Case Submission

We coordinate direct case submission to Dr. Yeh Ching Linn's department, including all documentation required for clinical review and appointment scheduling.

calendar_month

Appointment & Consultation Coordination

CancerFax manages appointment scheduling with Dr. Yeh Ching Linn's team, confirming availability and aligning timelines with your travel plans.

flight_takeoff

Travel, Visa & Logistics Support

We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.

support_agent

Follow-Up & Continuity of Care

After your consultation or treatment, CancerFax facilitates communication between Dr. Yeh Ching Linn's team and your home oncologist for seamless post-treatment follow-up.

quiz

Frequently Asked Questions About Dr. Yeh Ching Linn

Dr. Yeh Ching Linn is a Senior Consultant in the Department of Haematology at Singapore General Hospital. She also holds senior consultant appointments with the SingHealth Duke-NUS Blood Cancer Centre and the SingHealth Duke-NUS Transplant Centre, and academic appointments as Clinical Senior Lecturer at Yong Loo Lin School of Medicine, NUS, and Adjunct Associate Professor at Duke-NUS Medical School.

Dr. Yeh Ching Linn specialises in haematology, with a focused clinical interest in haematopoietic stem cell transplantation, cellular therapy, and cellular immunotherapy. Her research has centred on cytokine-induced killer cells and virus-specific T cells for leukaemia management after transplantation.

Her verified clinical scope includes acute leukaemia, acute lymphoblastic leukaemia, chronic lymphocytic leukaemia, chronic myeloid leukaemia, multiple myeloma, myelodysplastic syndromes, myelofibrosis, essential thrombocythaemia, polycythaemia vera, aplastic anaemia, and thalassaemia, as listed on her Singapore General Hospital profile.

Yes. Dr. Yeh Ching Linn's clinical interests include haematopoietic stem cell transplantation and cellular therapy. She is a Senior Consultant with the SingHealth Duke-NUS Transplant Centre, which provides autologous and allogeneic transplant services for eligible patients with blood cancers and bone marrow disorders.

CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Yeh Ching Linn at Singapore General Hospital, subject to hospital availability and case acceptance. Please submit your medical reports through CancerFax to begin the process.

A second-opinion request can be submitted through CancerFax with the patient's pathology reports, bone marrow biopsy results, imaging, treatment history, and relevant laboratory findings. The CancerFax team will review the documents, organise the case summary, and coordinate the next steps with Singapore General Hospital, subject to the doctor's availability and the hospital's international patient process.

sendGet Expert Oncology Guidance

Connect with Yeh Ching Linn Today

Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.

Free case review ยท No commitment ยท Response within 24 hours ยท Available in 12+ languages

Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.

upload_fileUpload ReportschatWhatsApp